Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fruhbeck, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fruhbeck, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 4 903-908, Copyright © 1999 by American Diabetes Association


ARTICLES

Pivotal role of nitric oxide in the control of blood pressure after leptin administration

G Fruhbeck
Department of Endocrinology, Clinica Universitaria de Navarra, University of Navarra, Pamplona, Spain. gfruhbeck@unav.es

Leptin administration has been shown to increase renal, adrenal, and lumbar sympathetic nerve activity. However, this generalized sympathoexcitatory activity is not always followed by an increase in arterial pressure. The present study tested the hypothesis that leptin induces a release of nitric oxide (NO) that opposes the pressor effect of sympathoexcitation. The effect of intravenous administration of leptin (10, 100, and 1,000 microg/kg body wt) or vehicle on blood pressure (BP), heart rate (HR), and serum nitrite/nitrate concentrations of anesthetized Wistar rats was examined. At 90 min after injection, the three leptin doses tested increased serum NO concentrations 20.5, 33.1, and 89.5%, respectively (P < 0.001 vs. baseline). The effect of leptin on NO concentrations was significantly dose-dependent on linear trend testing (P = 0.0001). In contrast, leptin did not change serum nitrite/nitrate concentrations of fa/fa rats. Leptin administration to Wistar rats under NO synthesis inhibition (N(omega)-nitro-L-arginine methyl ester [L-NAME]) produced a statistically significant increase (P < 0.05) in both systolic BP and mean arterial pressure as well as in HR (P < 0.01). Injection of leptin into rats with pharmacologically induced ganglionic blockade (chlorisondamine) was followed by a decrease in BP and HR to values significantly lower (P < 0.01) than those observed with chlorisondamine treatment alone. The leptin-induced hypotension observed in the setting of ganglionic blockade was blocked by L-NAME. These findings raise the possibility that the leptin-induced release of NO may contribute to the homeostasis of BP.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
R. Yang and L. A. Barouch
Leptin Signaling and Obesity: Cardiovascular Consequences
Circ. Res., September 14, 2007; 101(6): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Katagiri, T. Yamada, and Y. Oka
Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals
Circ. Res., July 6, 2007; 101(1): 27 - 39.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Rodriguez, A. Fortuno, J. Gomez-Ambrosi, G. Zalba, J. Diez, and G. Fruhbeck
The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism
Endocrinology, January 1, 2007; 148(1): 324 - 331.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Galvez, J. de Castro, D. Herold, G. Dubrovska, S. Arribas, M. C. Gonzalez, I. Aranguez, F. C. Luft, M. P. Ramos, M. Gollasch, et al.
Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1297 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Stein, E. Vasquez-Garibay, J. Kratzsch, E. Romero-Velarde, and G. Jahreis
Influence of Nutritional Recovery on the Leptin Axis in Severely Malnourished Children
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1021 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. M. Thule, A. G. Campbell, D. J. Kleinhenz, D. E. Olson, J. J. Boutwell, R. L. Sutliff, and C. M. Hart
Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E114 - E122.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
W. G Haynes
Role of leptin in obesity-related hypertension
Exp Physiol, September 1, 2005; 90(5): 683 - 688.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Knudson, U. D. Dincer, C. Zhang, A. N. Swafford Jr., R. Koshida, A. Picchi, M. Focardi, G. M. Dick, and J. D. Tune
Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H48 - H56.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. M. Minhas, S. A. Khan, S. V. Y. Raju, A. C. Phan, D. R. Gonzalez, M. W. Skaf, K. Lee, A. D. Tejani, A. P. Saliaris, L. A. Barouch, et al.
Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy
J. Physiol., June 1, 2005; 565(2): 463 - 474.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H.-F. Huang, B. Wang, X.-F. Yang, Q. Luo, and J.-Z. Sheng
Nitric Oxide Mediates Inhibitory Effect of Leptin on Insulin-Like Growth Factor I Augmentation of 17{beta}-Estradiol Production in Human Granulosa Cells
Biol Reprod, January 1, 2005; 72(1): 102 - 106.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. S. Fernandez-Alfonso
Regulation of Vascular Tone: The Fat Connection
Hypertension, September 1, 2004; 44(3): 255 - 256.
[Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers
Hypertension and Obesity
Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205.
[Abstract] [Full Text]


Home page
Recent Prog Horm ResHome page
K. Rahmouni and W. G. Haynes
Leptin and the Cardiovascular System
Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Werner and G. Nickenig
From Fat Fighter to Risk Factor: The Zigzag Trek of Leptin
Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 7 - 9.
[Full Text] [PDF]


Home page
EndocrinologyHome page
V. D. Dixit, M. Mielenz, D. D. Taub, and N. Parvizi
Leptin Induces Growth Hormone Secretion from Peripheral Blood Mononuclear Cells via a Protein Kinase C- and Nitric Oxide-Dependent Mechanism
Endocrinology, December 1, 2003; 144(12): 5595 - 5603.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Sader, M. Nian, and P. Liu
Leptin: A Novel Link Between Obesity, Diabetes, Cardiovascular Risk, and Ventricular Hypertrophy
Circulation, August 12, 2003; 108(6): 644 - 646.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Shirasaka, M. Takasaki, and H. Kannan
Cardiovascular effects of leptin and orexins
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R639 - R651.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.A Glader, L.S Birgander, S Soderberg, H.P Ildgruben, P Saikku, A Waldenstrom, and G.H Dahlen
Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis
Eur. Heart J., January 2, 2003; 24(2): 198 - 208.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Fortuno, A. Rodriguez, J. Gomez-Ambrosi, P. Muniz, J. Salvador, J. Diez, and G. Fruhbeck
Leptin Inhibits Angiotensin II-Induced Intracellular Calcium Increase and Vasoconstriction in the Rat Aorta
Endocrinology, September 1, 2002; 143(9): 3555 - 3560.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Mastronardi, W. H. Yu, and S. M. McCann
Resting and circadian release of nitric oxide is controlled by leptin in male rats
PNAS, April 16, 2002; 99(8): 5721 - 5726.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Carlyle, O. B. Jones, J. J. Kuo, and J. E. Hall
Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Hypertension, February 1, 2002; 39(2): 496 - 501.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Vecchione, A. Maffei, S. Colella, A. Aretini, R. Poulet, G. Frati, M. T. Gentile, L. Fratta, V. Trimarco, B. Trimarco, et al.
Leptin Effect on Endothelial Nitric Oxide Is Mediated Through Akt-Endothelial Nitric Oxide Synthase Phosphorylation Pathway
Diabetes, January 1, 2002; 51(1): 168 - 173.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. E. Wold, D. P. Relling, J. Duan, F. L. Norby, and J. Ren
Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous Hypertension: Role of JAK/STAT Pathway
Hypertension, January 1, 2002; 39(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. L. Mitchell, D. A. Morgan, M. L.G. Correia, A. L. Mark, W. I. Sivitz, and W. G. Haynes
Does Leptin Stimulate Nitric Oxide to Oppose the Effects of Sympathetic Activation?
Hypertension, November 1, 2001; 38(5): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Fruhbeck, J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E827 - E847.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. L. G. Correia, D. A. Morgan, W. I. Sivitz, A. L. Mark, and W. G. Haynes
Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure
Hypertension, March 1, 2001; 37(3): 936 - 942.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Shiuchi, H. Nakagami, M. Iwai, Y. Takeda, T.-X. Cui, R. Chen, Y. Minokoshi, and M. Horiuchi
Involvement of Bradykinin and Nitric Oxide in Leptin-Mediated Glucose Uptake in Skeletal Muscle
Endocrinology, February 1, 2001; 142(2): 608 - 612.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. FRUHBECK, J. GOMEZ-AMBROSI, and J. SALVADOR
Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes
FASEB J, February 1, 2001; 15(2): 333 - 340.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Kuo, O. B. Jones, and J. E. Hall
Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin
Hypertension, February 1, 2001; 37(2): 670 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. Winters, Z. Mo, E. Brooks-Asplund, S. Kim, A. Shoukas, D. Li, D. Nyhan, and D. E. Berkowitz
Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lepob) mice
J Appl Physiol, December 1, 2000; 89(6): 2382 - 2390.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. W. Nickola, L. E. Wold, P. B. Colligan, G.-J. Wang, W. K. Samson, and J. Ren
Leptin Attenuates Cardiac Contraction in Rat Ventricular Myocytes : Role of NO
Hypertension, October 1, 2000; 36(4): 501 - 505.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Uckaya, M. Ozata, A. Sonmez, C. Kinalp, T. Eyileten, N. Bingol, B. Koc, F. Kocabalkan, and I. C. Ozdemir
Is Leptin Associated with Hypertensive Retinopathy?
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 683 - 687.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.